Health Canada is reviewing generic versions of obesity medications, which could lead to cheaper options becoming available in Canada this summer. The potential availability of generic versions of drugs such as Ozempic is anticipated, although it is unclear how distribution will be affected globally. The development may have varying implications for different regions, including british columbia.